首页 | 本学科首页   官方微博 | 高级检索  
     

马蔺子素放射增敏的前瞻性研究(附120例临床分析)
引用本文:单娟,葛红,陆寓非,侯秉森. 马蔺子素放射增敏的前瞻性研究(附120例临床分析)[J]. 中国肿瘤临床, 2003, 30(5): 328-330
作者姓名:单娟  葛红  陆寓非  侯秉森
作者单位:河南省肿瘤医院放疗科,郑州市,450008
摘    要:目的:观察马蔺子素的放射增敏作用。方法:收集120例恶性肿瘤患者以随机分组联合应用安卡胶囊(马蔺子素)进行前瞻性研究。结果:近期疗效显示,综合组CR率66.67%,明显优于单放组35.00%,P<0.005,统计学上具有显著性意义。远期疗效:对于食管癌,肺癌或有淋巴结转移者,综合组1、3、5年生存率均高于单放组。结论:马蔺子素的放射增敏作用疗效确定。

关 键 词:恶性肿瘤 马蔺子素 放射治疗
文章编号:1000-8179(2003)05-0328-03
修稿时间:2002-06-14

Prospective Study of Radiosensitizing Activity of Irisquinone in Combination Treatment of Malignant Neoplasms
ShanJuanGeHongLuYufeiRadiotherapyDepartment,HenanTumorHospital,Zhengzhou. Prospective Study of Radiosensitizing Activity of Irisquinone in Combination Treatment of Malignant Neoplasms[J]. Chinese Journal of Clinical Oncology, 2003, 30(5): 328-330
Authors:ShanJuanGeHongLuYufeiRadiotherapyDepartment  HenanTumorHospital  Zhengzhou
Abstract:Objective:To observe the radiosensitizing activity of irisq ui none.Methods:One hun dred and twenty patients with malignant neoplasm were di vided at random into two groups:Group A,Combination group to whom radiotherap y was given in association with irisquinone;Group B,con trol group to whom rad iotherapy alone was given.Results:Short-term results revealed that the CR rat e of the primary foci in group A was obviously superior than that of group B.( P<0.005)Long-term result revealed that the total1,3,5-year surviva l rate group A was Superior than that of group B,in esophageal carcinomain1u ng canceror with lymphatic metastases.Conclusion:The radiosensi-tizing acti vity of irisquinone is effective.
Keywords:Malignant neoplasm Irisquinone Rad iosensitization
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号